HPV in HIV-Infected Women: Implications for Primary Prevention
about
Editorial: HPV-Associated Cancers, Socio-Economic Disparity, and VaccinationDiversity of high risk human papilloma viruses in women treated with antiretroviral and in healthy controls and discordance with cervical dysplasia in the South of BeninA novel candidate MS2 phage VLP vaccine displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.Prevalence of HPV infection among HIV-positive and HIV-negative women in Central/Eastern Italy: Strategies of prevention.Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.
P2860
HPV in HIV-Infected Women: Implications for Primary Prevention
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
HPV in HIV-Infected Women: Implications for Primary Prevention
@ast
HPV in HIV-Infected Women: Implications for Primary Prevention
@en
HPV in HIV-Infected Women: Implications for Primary Prevention
@nl
type
label
HPV in HIV-Infected Women: Implications for Primary Prevention
@ast
HPV in HIV-Infected Women: Implications for Primary Prevention
@en
HPV in HIV-Infected Women: Implications for Primary Prevention
@nl
prefLabel
HPV in HIV-Infected Women: Implications for Primary Prevention
@ast
HPV in HIV-Infected Women: Implications for Primary Prevention
@en
HPV in HIV-Infected Women: Implications for Primary Prevention
@nl
P2093
P2860
P356
P1476
HPV in HIV-Infected Women: Implications for Primary Prevention
@en
P2093
Atsushi Morishita
Erin N Kobetz
Isabella Rosa-Cunha
James H Hnatyszyn
JoNell E Potter
Joseph A Lucci
Nathalie Dauphin McKenzie
Parvin Ganjei-Azar
Toumy Guettouche
Tulay Koru-Sengul
P2860
P356
10.3389/FONC.2014.00179
P577
2014-08-12T00:00:00Z